Association of Blood Pressure and Hypertension with Alcohol Consumption in HIV-Infected White and Nonwhite Patients

Table 1

Characteristics of HIV-infected individuals according to skin color (𝑛 (%) or mean ± SD).

	Total (𝑛=1240)	Whites (𝑛=710)	Nonwhites (𝑛=530)	𝑃 value
Male	628 (50.6)	391 (55.1)	237 (44.7)	<0.001
Age (years)	39.1±10.0	39.3±10.3	38.9±9.7	0.5
Educational attainment (years)	7.5±4.1	8.3±4.2	6.4±3.7	<0.001
Smoking	525 (42.3)	298 (42.0)	227 (42.8)	0.4
Physical activity				0.049
Low	321 (25.9)	199 (28.0)	122 (23.0)
Moderate	398 (32.1)	232 (32.7)	166 (31.3)
High	521 (42.0)	279 (39.3)	242 (45.7)
Alcohol consumption				0.7
Abstemious	414 (33.4)	233 (32.8)	181 (34.2)
Social drinking	757 (61.0)	440 (62.0)	317 (59.8)
Abusive drinking	69 (5.6)	37 (5.2)	32 (6.0)
Frequency of alcohol consumption				0.7
Abstemious	414 (33.4)	233 (32.8)	181 (34.2)
Monthly	440 (35.5)	249 (35.1)	191 (36.0)
Weekly	386 (31.1)	228 (32.1)	158 (29.8)
Binge drinking	211 (17.0)	117 (55.5)	94 (44.5)	0.7
Abstemious	414 (33.4)	233 (32.8)	181 (34.2)
No	616 (49.7)	360 (50.7)	255 (48.1)
Yes	210 (16.9)	117 (16.5)	94 (17.7)
Body mass index (kg/m²)	24.9±4.4	24.8±4.3	25.0±4.7	0.4
Systolic blood pressure (mmHg)	121.8±18.2	121.8±17.7	121.8±18.8	0.9
Diastolic blood pressure (mmHg)	76.6±11.4	76.0±10.7	77.3±12.3	0.06
Hypertension	241 (19.4)	120 (16.9)	121 (22.8)	0.009
Time since HIV infection (years)				0.005
≥6.0	404 (32.6)	250 (35.3)	154 (29.1)
3.0–5.9	350 (28.2)	176 (24.8)	174 (32.8)
<3.0	485 (39.1)	283 (39.9)	202 (38.1)
HIV/HCV coinfection	261 (22.2)	143 (21.2)	118 (23.5)	0.3
AIDS diagnosis	892 (72.2)	510 (72.0)	382 (72.3)	0.9
Lifetime HAART use	815 (65.7)	467 (65.8)	348 (65.7)	0.9
Lifetime protease inhibitor use	468 (37.7)	277 (39.0)	191 (36.0)	0.3
CD4 (cell/mm^3)				0.08
<350	476 (38.8)	258 (36.7)	218 (41.6)
≥350	751 (61.2)	445 (63.3)	306 (58.4)

HAART: highly active antiretroviral therapy; HCV: hepatitis C virus; HIV: human immunodeficiency virus; SD: standard deviation.